Teva Raises 2026 Revenue Forecast After Third-Quarter Profit Beat
Teva reported higher-than-expected third-quarter profit, with branded-drug sales offsetting declines in generics, and raised its 2026 forecasts.
By Steven ScheerIsraeli drugmaker Teva Pharmaceutical Industries TASE:TEVA, TASE:TEVA reported a higher-than-expected third-quarter profit on Tuesday, as strong sales of a trio of its branded medicines offset declines in generic drugs.Teva raised its 2026 forecasts and Chief Executive Richard Fran…